HER2 Loss in HER2-positive Gastric or Gastroesophageal Cancer After Trastuzumab Therapy: Implication for Further Clinical Research
International Journal of Cancer - United States
doi 10.1002/ijc.30408
Full Text
Open PDFAbstract
Available in full text
Date
September 16, 2016
Authors
Publisher
Wiley